LUIS LUNA: Open Payments
NPI 1558453225 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 51 payments from 10 companies in 2025. Trend: 2023 $1,659 · 2024 $1,488 · 2025 $1,143
Food & beverage: $1,143
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 19 | $532 |
| AstraZeneca Pharmaceuticals LP | 7 | $189 |
| Amgen Inc. | 10 | $154 |
| Dexcom, Inc. | 3 | $73 |
| Novo Nordisk Inc | 4 | $65 |
| PFIZER INC. | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Validus Pharmaceuticals LLC | 2 | $28 |
| Metacel Pharmaceuticals LLC | 1 | $18 |
| Seqirus USA Inc | 1 | $14 |
Products named: JARDIANCE, FARXIGA, OTEZLA, Dexcom G6 Transmitter, EVENITY, AIRSUPRA, REPATHA, Ozempic.
Industry payments across NJ — which companies pay providers there.
